Performance

BRVE -34.70%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
BRVE	+4.62%	-34.70%*	-34.70%*	—	-41.95%*	-1.59*	0.00%*

Summary

BRVE at a glance

BRVE returned -34.70% since Aug 6, 2026. Its worst drop since then was -41.95%, smaller than 34% of stocks on Redstone, and its Sharpe ratio of -1.59 beats 0% of stocks on Redstone. It hasn't paid a dividend since it listed.

Ranking

How BRVE ranks

Dividend Yield Rank *

Current Drawdown

-35.13%

Rolling Volatility

69.98%

Actions

Metrics

Risk Indicators*

Alpha-120.79%

Beta1.04x

Sharpe-1.59

Sortino-1.93

Omega0.77

Calmar-0.83

Martin-5.49

Profile

About BRVE

Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $1.8B
Listed: Aug 2026
Headquarters: San Francisco, CA
Website: braveheart.bio

Comparisons

BRVE: Braveheart Bio, Inc.

BRVE at a glance

How BRVE ranks

Current Drawdown

Rolling Volatility

About BRVE

Related comparisons